copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Titan Pharmaceuticals, Inc. (TTNP) Titan Pharmaceuticals, Inc Nasdaq: TTNP Volume Day Low High 52-Week Low High Average Volume January 17, 2025 Saying Farewell and Sharing Thoughts on an Exciting Time for NIH Research Saying Farewell and Sharing Thoughts on an Exciting Time for NIH Research: Read Article
Titan Pharmaceuticals, Inc. (TTNP) - Yahoo Finance Find the latest Titan Pharmaceuticals, Inc (TTNP) stock quote, history, news and other vital information to help you with your stock trading and investing
Investor Relations :: Titan Pharmaceuticals, Inc. (TTNP) Titan is advancing the treatment of select chronic diseases by developing therapeutics based on its proprietary long-term, continuous drug delivery platform, ProNeura®
Titan Pharmaceuticals - Wikipedia Titan Pharmaceuticals, Inc is a biopharmaceutical company based in San Francisco, CA, developing proprietary therapeutics primarily for treating central nervous system ("CNS") disorders In September 2018, Titan Pharmaceuticals underwent an IPO wherein it raised $9 5 million in gross proceeds [3]
About Titan Pharmaceuticals Titan Pharmaceuticals, Inc was incorporated as a Delaware corporation in 1992 Titan previously focused on developing therapeutics utilizing the proprietary long-term drug delivery platform, ProNeura®, for the treatment of select chronic diseases for which steady state delivery of a drug has the potential to provide an efficacy and or safety
TITAN PHARMACEUTICAL Leading products of TITAN include Cefuroxime sodium, Cefuroxime axetil, Cefixime, Cefminoxime sodium, etc And TITAN is the largest exporter of Cefuroxime APIs in China Home
Titan Pharmaceuticals, Inc. common stock - Google Titan Pharmaceuticals, Inc is a biopharmaceutical company based in San Francisco, CA, developing proprietary therapeutics primarily for treating central nervous system disorders
Titan Pharmaceuticals Inc. - MarketWatch Titan Pharmaceuticals, Inc engages in the development of therapeutics for the treatment of chronic diseases utilizing its long-term, continuous drug delivery platform, proNeura
Company Information :: Titan Pharmaceuticals, Inc. (TTNP) Titan is a development-stage biotechnology company developing proprietary therapeutics using its clinically proven ProNeura ® long-term, continuous drug delivery technology The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions where maintaining consistent, around-the-clock